ArticleBMC cancer2021
Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients.
Li Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it